These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38683656)
1. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing. Liang S; Ma N; Li X; Yun K; Meng QF; Ma K; Yue L; Rao L; Chen X; Wang Z Nano Lett; 2024 Jun; 24(23):6872-6880. PubMed ID: 38683656 [TBL] [Abstract][Full Text] [Related]
2. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing. Li S; Song Z; Liu C; Chen XL; Han H ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942 [TBL] [Abstract][Full Text] [Related]
3. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing. Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503 [TBL] [Abstract][Full Text] [Related]
4. Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing. Rui Y; Wilson DR; Choi J; Varanasi M; Sanders K; Karlsson J; Lim M; Green JJ Sci Adv; 2019 Dec; 5(12):eaay3255. PubMed ID: 31840076 [TBL] [Abstract][Full Text] [Related]
5. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein. Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216 [TBL] [Abstract][Full Text] [Related]
6. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Wei T; Cheng Q; Min YL; Olson EN; Siegwart DJ Nat Commun; 2020 Jun; 11(1):3232. PubMed ID: 32591530 [TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells. Bloomer H; Khirallah J; Li Y; Xu Q Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo. Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664 [TBL] [Abstract][Full Text] [Related]
9. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum. Kim H; Choi J; Won KH BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008 [TBL] [Abstract][Full Text] [Related]
10. Engineering self-deliverable ribonucleoproteins for genome editing in the brain. Chen K; Stahl EC; Kang MH; Xu B; Allen R; Trinidad M; Doudna JA Nat Commun; 2024 Feb; 15(1):1727. PubMed ID: 38409124 [TBL] [Abstract][Full Text] [Related]
11. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing. Im SH; Jang M; Park JH; Chung HJ J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947 [TBL] [Abstract][Full Text] [Related]
12. Biologically produced and metal-organic framework delivered dual-cut CRISPR/Cas9 system for efficient gene editing and sensitized cancer therapy. Yu J; Tang M; Zhou Z; Wei Z; Wan F; Hou S; Li Q; Li Y; Tian L Acta Biomater; 2024 Apr; 178():296-306. PubMed ID: 38417646 [TBL] [Abstract][Full Text] [Related]
13. Genome editing using preassembled CRISPR-Cas9 ribonucleoprotein complexes in Fusarium graminearum. Lee N; Park J; Kim JE; Shin JY; Min K; Son H PLoS One; 2022; 17(6):e0268855. PubMed ID: 35657788 [TBL] [Abstract][Full Text] [Related]
14. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins. Metzger JM; Wang Y; Neuman SS; Snow KJ; Murray SA; Lutz CM; Bondarenko V; Felton J; Gimse K; Xie R; Li D; Zhao Y; Flowers MT; Simmons HA; Roy S; Saha K; Levine JE; Emborg ME; Gong S Biomaterials; 2023 Feb; 293():121959. PubMed ID: 36527789 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics. Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365 [TBL] [Abstract][Full Text] [Related]
16. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea. Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893 [TBL] [Abstract][Full Text] [Related]